Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial, Journal of Clinical Oncology, January 2022, American Society of Clinical Oncology (ASCO),
DOI: 10.1200/jco.21.02050.
You can read the full text:

Read

Contributors

The following have contributed to this page